Infectious Diseases (except HIV/AIDS)

  1. Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China

    1. Jianfeng Wu
    2. Jianqiang Huang
    3. Guochao Zhu
    4. Yihao Liu
    5. Han Xiao
    6. Qian Zhou
    7. Xiang Si
    8. Hui Yi
    9. Cuiping Wang
    10. Daya Yang
    11. Shuling Chen
    12. Xin Liu
    13. Zelong Liu
    14. Qiongya Wang
    15. Qingquan Lv
    16. Ying Huang
    17. Yang Yu
    18. Xiangdong Guan
    19. Yanbing Li
    20. Krishnarajah Nirantharakumar
    21. KarKeung Cheng
    22. Sui Peng
    23. Haipeng Xiao

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Early safety indicators of COVID-19 convalescent plasma in 5000 patients

    1. Michael J. Joyner
    2. R. Scott Wright
    3. DeLisa Fairweather
    4. Jonathon W. Senefeld
    5. Katelyn A. Bruno
    6. Stephen A. Klassen
    7. Rickey E. Carter
    8. Allan M. Klompas
    9. Chad C. Wiggins
    10. John R.A. Shepherd
    11. Robert F. Rea
    12. Emily R. Whelan
    13. Andrew J. Clayburn
    14. Matthew R. Spiegel
    15. Patrick W. Johnson
    16. Elizabeth R. Lesser
    17. Sarah E. Baker
    18. Kathryn F. Larson
    19. Juan G. Ripoll
    20. Kylie J. Andersen
    21. David O. Hodge
    22. Katie L. Kunze
    23. Matthew R. Buras
    24. Matthew N.P. Vogt
    25. Vitaly Herasevich
    26. Joshua J. Dennis
    27. Riley J. Regimbal
    28. Philippe R. Bauer
    29. Janis E. Blair
    30. Camille M. Van Buskirk
    31. Jeffrey L. Winters
    32. James R. Stubbs
    33. Nigel S. Paneth
    34. Nicole C. Verdun
    35. Peter Marks
    36. Arturo Casadevall

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study

    1. Jean Regina
    2. Matthaios Papadimitriou-Olivgeris
    3. Raphaël Burger
    4. Marie-Annick Le Pogam
    5. Tapio Niemi
    6. Paraskevas Filippidis
    7. Jonathan Tschopp
    8. Florian Desgranges
    9. Benjamin Viala
    10. Eleftheria Kampouri
    11. Laurence Rochat
    12. David Haefliger
    13. Mehdi Belkoniene
    14. Carlos Fidalgo
    15. Antonios Kritikos
    16. Katia Jaton
    17. Laurence Senn
    18. Pierre-Alexandre Bart
    19. Jean-Luc Pagani
    20. Oriol Manuel
    21. Loïc Lhopitallier

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Beneficial effect of corticosteroids in severe COVID-19 pneumonia: a propensity score matching analysis

    1. Tomasz Chroboczek
    2. Marie Lacoste
    3. Chloe Wackenheim
    4. Thibaut Challan-Belval
    5. Benjamin Amar
    6. Thomas Boisson
    7. Jason Hubac
    8. Dominique Leduc
    9. Colleen Masse
    10. Victor Dechaene
    11. Laetitia Touhiri-Maximin
    12. Sandrine Megessier
    13. Camille Lassale

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection

    1. Vijendra Ramlall
    2. Phyllis M. Thangaraj
    3. Cem Meydan
    4. Jonathan Foox
    5. Daniel Butler
    6. Jacob Kim
    7. Ben May
    8. Jessica K. De Freitas
    9. Benjamin S. Glicksberg
    10. Christopher E. Mason
    11. Nicholas P. Tatonetti
    12. Sagi D. Shapira

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2

    1. Dennis Lapuente
    2. Clara Maier
    3. Pascal Irrgang
    4. Julian Hübner
    5. Antonia Sophia Peter
    6. Markus Hoffmann
    7. Armin Ensser
    8. Katharina Ziegler
    9. Thomas H. Winkler
    10. Torsten Birkholz
    11. Andreas E. Kremer
    12. Philipp Steininger
    13. Klaus Korn
    14. Frank Neipel
    15. Klaus Überla
    16. Matthias Tenbusch

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Evolving Epidemiology and Effect of Non-pharmaceutical Interventions on the Epidemic of Coronavirus Disease 2019 in Shenzhen, China

    1. Suli Huang
    2. Zhen Zhang
    3. Yongsheng Wu
    4. Shujiang Mei
    5. Yuan Li
    6. Xu Xie
    7. Xiaojian Liu
    8. Xiujuan Tang
    9. Dongfeng Kong
    10. Xiaoliang Wu
    11. Yu Wu
    12. Lan Wei
    13. Ziquan Lv
    14. Shuyuan Yu
    15. Ying Wen
    16. Guohong Zhou
    17. Tianmu Chen
    18. Tiejian Feng
    19. Xuan Zou

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis

    1. Md Mostaured Ali Khan
    2. Md Nuruzzaman Khan
    3. Md Golam Mustagir
    4. Juwel Rana
    5. Md Saiful Islam
    6. Md Iqbal Kabir

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens

    1. Colin R. Zamecnik
    2. Jayant V. Rajan
    3. Kevin A. Yamauchi
    4. Sabrina A. Mann
    5. Rita P. Loudermilk
    6. Gavin M. Sowa
    7. Kelsey C. Zorn
    8. Bonny D. Alvarenga
    9. Christian Gaebler
    10. Marina Caskey
    11. Mars Stone
    12. Philip J. Norris
    13. Wei Gu
    14. Charles Y. Chiu
    15. Dianna Ng
    16. James R. Byrnes
    17. Xin X. Zhou
    18. James A. Wells
    19. Davide F. Robbiani
    20. Michel C. Nussenzweig
    21. Joseph L. DeRisi
    22. Michael R. Wilson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E

    1. Luisa A. Ikner
    2. Jason R. Torrey
    3. Patricia M. Gundy
    4. Charles P. Gerba

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 81 of 716 Next